top of page

Press Room

All the News About Vesica Health

Press Releases

August 8, 2024

Vesica Health Announces Formation of Scientific Advisory Board

Read More

May 3, 2024

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection

Read More

March 26, 2024

Vesica Health's AssureMDx: Revolutionizing Surveillance for Bladder Cancer Patients

Read More

January 2, 2024

Vesica Health to Present at the Seed Showcase, Part of Biotech Showcase, The Investor Conference for Innovators

Read More

October 31, 2023

Vesica Health Appoints Distinguished Urologic Oncologist Dr. William T. Lowrance to Chief Medical Officer

Read More

October 19, 2023

Vesica Health Announces the Appointment of Recognized Industry Leaders to Newly Formed Board of Directors

Read More

October 9, 2023

Vesica Health Announces Publication of Study Demonstrating AssureMDx Meaningfully Improves Identification of Hematuria Patients at High Risk for Bladder Cancer

Read More

In The News

May 8, 2024

Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection

Read More

May 6, 2024

Vesica Health rolls out new test for bladder cancer detection

Read More

April 5, 2024

Vesica Health Builds Data for Follow-On Applications of Bladder Cancer Test

Read More

March 27, 2024

Urine-based assay demonstrates predictive efficacy in MIBC

Read More

October 20, 2023

Startup Vesica Health to Revive MDxHealth Bladder Cancer Assay Boosted by New Clinical Impact Data

Read More

October 11, 2023

Urine-Based Genomic Test Identifies Hematuria Patients at High Risk for Bladder Cancer

Read More

October 10, 2023

Urine-based genomic test enhances current risk assessments for bladder cancer

Read More
bottom of page